Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652337 · ClinicalTrials.gov registry record · NA
Meibomian Gland Dysfunction Management
A NA study of Meibomian Gland Dysfunction and Contact Lens Discomfort, sponsored by University of the Incarnate Word.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03652337 is a NA study of Meibomian Gland Dysfunction and Contact Lens Discomfort that is active but no longer recruiting, run by University of the Incarnate Word. The registered enrollment target is 60 participants, below the 95-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03652337, a NA study of Meibomian Gland Dysfunction and Contact Lens Discomfort, is active but no longer recruiting, sponsored by University of the Incarnate Word.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare electronic debridement of the eyelid margin (BlephEx) to manual debridement of the eyelid margin as treatment options for patients intolerant to contact lens wear consequent to Meibomian gland dysfunction.
Conditions Studied
Interventions
- DEVICE BlephEx
- DEVICE Manual debridement
Study Locations (1)
Texas
- Rosenberg School of Optometry - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-05-10 |
| Est. Completion | 2019-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652337
The ClinicalTrials.gov registry entry for NCT03652337 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (37% lower). The listed sponsor is University of the Incarnate Word, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Meibomian Gland Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which BlephEx is the first listed.
NCT03652337 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03652337 about?
NCT03652337 is a clinical study titled "Meibomian Gland Dysfunction Management". The purpose of this study is to compare electronic debridement of the eyelid margin (BlephEx) to manual debridement of the eyelid margin as treatment options for patients intolerant to contact lens wear consequent to Meibomian gland dysfunction.
What is the current status of trial NCT03652337?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2018-05-10. Estimated completion is 2019-04-10.
What conditions does trial NCT03652337 study?
This clinical trial studies the following conditions: Meibomian Gland Dysfunction, Contact Lens Discomfort.
What interventions are being tested in trial NCT03652337?
The interventions under investigation include: BlephEx (DEVICE), Manual debridement (DEVICE).
Who is sponsoring clinical trial NCT03652337?
This trial is sponsored by University of the Incarnate Word, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03652337 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meibomian Gland Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
COMPLETED · NA
-
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
COMPLETED · NA
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
COMPLETED · NA
-
Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease
COMPLETED · NA
-
Tear Film Innovations iLux Safety Study
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.